Related Experiment Video
Updated: Feb 4, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Circulating cell-free DNA as a biomarker for immune function and disease progression in HIV-infected patients: a
Lu Cheng1, Haokun Gao2, Meixin Fang3
1Clinical Laboratory of Zhejiang Hospital, Hangzhou, 310007, China.
Insights
Circulating cell-free DNA (ccfDNA) levels correlate with immune dysfunction in HIV-1 patients. This biomarker shows potential for monitoring immune status and disease progression in individuals with HIV-1.
Area of Science:
- Immunology
- Virology
- Biomarker Discovery
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection leads to immune deficiency, primarily through CD4+ T-cell depletion.
- Monitoring immune function and disease progression is crucial for managing HIV-1.
Purpose of the Study:
- To explore circulating cell-free DNA (ccfDNA) as a potential biomarker for immune status and disease progression in HIV-1-infected individuals.
- To assess the relationship between ccfDNA levels and immunological/virological parameters in HIV-1 patients.
Main Methods:
- Cross-sectional study involving 79 HIV-1 patients on antiretroviral therapy and 35 controls.
- Measurement of ccfDNA levels, CD4+ T-cell counts, immune activation/apoptosis markers, and viral load.
- Correlation and receiver operating characteristic (ROC) curve analyses were performed.
Main Results:
- ccfDNA showed a negative correlation with CD4+ T-cell counts and a positive correlation with viral load.
- ccfDNA levels were significantly associated with markers of T-cell immune activation and apoptosis.
- ROC analysis indicated ccfDNA's potential as a complementary biomarker for monitoring HIV-1 patients, with an area under the curve of 0.799.
Conclusions:
- ccfDNA levels are closely linked to immune dysfunction in HIV-1-infected individuals.
- ccfDNA may serve as a valuable complementary biomarker for monitoring immune status and disease progression in HIV-1 management.
Background:
Human immunodeficiency virus type 1 (HIV-1) causes immune deficiency, particularly CD4+T-cell depletion. This cross-sectional study explored circulating cell-free DNA (ccfDNA) as a biomarker for immune function and disease progression in HIV-1-infected individuals.
Methods:
We measured ccfDNA levels, CD4+T-cell counts, immune activation/apoptosis markers, and viral load in 79 patients receiving antiretroviral therapy (37 immune responders, 42 non-responders) and 35 controls. Correlation and receiver operating characteristic (ROC) curve analysis were performed to assess relationships between ccfDNA and immunological/virological parameters.
Results:
ccfDNA negatively correlated with CD4+T-cell counts (r = - 0.78, P < 0.01) and positively correlated with viral load (r = 0.58, P < 0.01) and T-cell immune activation/apoptosis markers (r = 0.78 ~ 0.89, P < 0.01). Multivariate regression showed CD4+T-cell counts independently associated with lower ccfDNA, while CD4+AnnexinV+, CD8+PD1+, and CD8+AnnexinV+T cells correlated with higher ccfDNA. ROC analysis (area under curve = 0.799) indicated ccfDNA's potential as a complementary biomarker for monitoring HIV-1 patients.
Conclusions:
Preliminary evidence from this study indicates that ccfDNA levels are closely linked to immune dysfunction and may have potential as a complementary biomarker for monitoring immune status in HIV-1-infected patients.
Related Concept Videos
Cross-Sectional Research
What is the Immune System?
Finding Volume Using Cross-Sectional Area
Profile Leveling and Cross Sections
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...

